Menu

Ekso Bionics Holdings, Inc. EKSO

Full chart Compare
Set alert

Price alert · EKSO

All alert types
15.90 USD 0.00 (+0.00%)

Jul 2, 2026, 3:24 PM EDT

15.75 Day range 18.12

52-week range unavailable

YTD
+84.03%
1 year
+165.00%

Revenue & Expenses

Other Income → Expenses: $1.63MExpenses → Selling, General & Admin: $17.14MExpenses → Research & Development: $3.03MGross Profit → Expenses: $6.84MRevenue → Gross Profit: $6.84MRevenue → Cost of Revenue: $5.95MNet Loss → Expenses: $11.70MOther Income$1.63MGross Profit$6.84MNet Loss$11.70MCost of Revenue$5.95MExpenses$20.17MSelling, General & Admin$17.14MResearch & Development$3.03MRevenue$12.80M

Latest period ending Dec 31, 2025 · select a line to chart its full history

EKSO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
12.80M17.93M18.28M12.91M11.25M
6.84M9.51M9.08M6.21M6.75M
-13.33M-10.46M-15.11M-15.56M-13.83M
-11.70M-11.33M-15.20M-15.08M-9.76M
-4.91-8.43-16.50-17.40-13.20
EKSO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.17M6.49M8.64M20.52M40.41M
20.11M26.65M28.92M40.90M49.17M
11.08M13.95M16.31M15.46M11.95M
4.64M5.98M7.17M7.50M2.22M
9.03M12.71M12.61M25.44M37.22M
EKSO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-11.80M-9.85M-12.05M-14.69M-11.16M
-188.00K-37.00K-157.00K-5.17M-59.00K
6.63M7.77M348.00K038.71M
-188.00K-37.00K-157.00K-175.00K-59.00K
-5.32M-2.15M-11.89M-19.88M27.54M